Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
Kattakuzhy, MD, joins The UMB Pulse this month to talk about her research exploring whether semaglutide (a GLP-1 medication widely used for diabetes and weight management) could help reduce cravings and improve outcomes for people with stimulant use disorder
Potential long-term complications for the patients include duodenal ulcers, intestinal metaplasia with dysplasia, gastric adenocarcinoma (non-cardia intestinal-type), and spontaneous diffuse gastric cancer (29)
- Week 4: Noticeably brighter complexion with reduced dark spots and more even tone
Clinicians must nevertheless balance these impressive cardiovascular benefits against practical considerations
US$ 25.82
US$ 21.91
US$ 22.87
US$ 24.02
US$ 25.44
US$ 20.86
US$ 24.86
